Sanofi (VIE:SANO)

Austria flag Austria · Delayed Price · Currency is EUR
85.40
+0.79 (0.93%)
At close: Dec 5, 2025
-6.46%
Market Cap 102.91B
Revenue (ttm) 45.93B
Net Income (ttm) 9.11B
Shares Out n/a
EPS (ttm) 7.39
PE Ratio 11.29
Forward PE 10.31
Dividend 3.92 (4.59%)
Ex-Dividend Date May 12, 2025
Volume 129
Average Volume 302
Open 84.62
Previous Close 84.61
Day's Range 84.62 - 85.53
52-Week Range 76.82 - 110.34
Beta n/a
RSI 44.79
Earnings Date Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 82,878
Stock Exchange Vienna Stock Exchange
Ticker Symbol SANO
Full Company Profile

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial Statements

News

There is no news available yet.